Oklahoma 2022 Regular Session

Oklahoma House Bill HB4288 Compare Versions

OldNewDifferences
11
22
3-SENATE FLOOR VERSION - HB4288 SFLR Page 1
4-(Bold face denotes Committee Amendments) 1
3+ENGR. H. B. NO. 4288 Page 1 1
54 2
65 3
76 4
87 5
98 6
109 7
1110 8
1211 9
1312 10
1413 11
1514 12
1615 13
1716 14
1817 15
1918 16
2019 17
2120 18
2221 19
2322 20
2423 21
2524 22
2625 23
2726 24
2827
29-SENATE FLOOR VERSION
30-April 11, 2022
31-AS AMENDED
32-
3328 ENGROSSED HOUSE
3429 BILL NO. 4288 By: Marti, Talley, Davis and
3530 McDugle of the House
3631
3732 and
3833
3934 Paxton of the Senate
4035
4136
4237
4338
4439
45-[ Oklahoma Medical Marijuana and Patient Protection
46-Act - inclusion of expiration or use by dates -
47- emergency ]
48-
49-
40+An Act relating to medical marijuana; amending 63
41+O.S. 2021, Section 427.18, which re lates to the
42+Oklahoma Medical Marijuana and Patient Protection
43+Act; requiring the inclusion of expiration or use by
44+dates; directing the Oklahoma Medical Marijuan a
45+Authority to promulgate rules; and declaring an
46+emergency.
5047
5148
5249
5350 BE IT ENACTED BY THE P EOPLE OF THE STATE OF OKLAHOMA:
5451 SECTION 1. AMENDATORY 63 O.S. 2021, Section 427.18, is
5552 amended to read as follows:
5653 Section 427.18 A. An Oklahoma medical marijuana business sha ll
5754 not sell, transfer or otherwise distribute medical marijuana or
5855 medical marijuana product t hat has not been packaged and labeled in
5956 accordance with this sec tion and rules promulgated by the State
6057 Commissioner of Health.
6158 B. A medical marijuana dispensa ry shall return medical
6259 marijuana and medical marijuan a product that does not meet packaging
6360 or labeling requirements in this section or rules promulgated
6461 pursuant thereto to the entity who transferred it to the dispensary .
62+The medical marijuana dispensar y shall document to whom the item was
6563
66-SENATE FLOOR VERSION - HB4288 SFLR Page 2
67-(Bold face denotes Committee Amendments) 1
64+ENGR. H. B. NO. 4288 Page 2 1
6865 2
6966 3
7067 4
7168 5
7269 6
7370 7
7471 8
7572 9
7673 10
7774 11
7875 12
7976 13
8077 14
8178 15
8279 16
8380 17
8481 18
8582 19
8683 20
8784 21
8885 22
8986 23
9087 24
9188
92-The medical marijuana dispensary shall document to whom the item was
9389 returned, what was returned and the date of the return or dispose of
9490 any usable marijuana that does not meet these require ments in
9591 accordance with the Oklahoma Medical Marijuana and Patient
9692 Protection Act.
9793 C. 1. Medical marijuana packaging shall be packaged to
9894 minimize its appeal to children and shall not depi ct images other
9995 than the business name logo of the medical mariju ana producer and
10096 image of the product.
10197 2. A medical marijuana business shall not place any co ntent on
10298 a container in a manner that reasonably appears to target
10399 individuals under the age of t wenty-one (21) including, but not
104100 limited to, cartoon characters or similar images.
105101 3. Labels on a container shall not include any false or
106102 misleading statements.
107103 4. No container shall be intentionally or knowingl y labeled so
108104 as to cause a reasonable pat ient confusion as to whether the medical
109105 marijuana, medical marij uana concentrate or medical marijuana
110106 product is a trademarked product or labeled in a manne r that
111107 violates any federal trademark law or regulation.
112108 5. The label on the container shall not m ake any claims
113109 regarding health or physical benefits to the patie nt.
110+6. All medical marijuana, medical marijuana concentrate and
111+medical marijuana product s shall be in a child-resistant container
112+at the point of transfer to the patient or caregiver.
114113
115-SENATE FLOOR VERSION - HB4288 SFLR Page 3
116-(Bold face denotes Committee Amendments) 1
114+ENGR. H. B. NO. 4288 Page 3 1
117115 2
118116 3
119117 4
120118 5
121119 6
122120 7
123121 8
124122 9
125123 10
126124 11
127125 12
128126 13
129127 14
130128 15
131129 16
132130 17
133131 18
134132 19
135133 20
136134 21
137135 22
138136 23
139137 24
140138
141-6. All medical marijuana, medical marijuana concentrate and
142-medical marijuana products shall be in a child-resistant container
143-at the point of transfer to the patient or caregiver.
144139 7. If the medical marijuana product is perishable, the label on
145140 the container of the product shall include a maximum six-month
146141 expiration date or a use by date if the medical marijuana product
147142 has not undergone stability testing. By November 1, 2022, the
148143 Authority shall promulgate rules establishing stability testing
149144 standards and requirements.
150145 D. The State Department of Health shall develop minimum
151146 standards for packaging and labeling of medical marijuana and
152147 medical marijuana products. Such standards shall include, but not
153148 be limited to, the required contents of labels to be affixed to all
154149 medical marijuana and medical marijuana products prior to transfer
155150 to a licensed patient or caregiver, which shall include, at a
156151 minimum:
157152 1. THC and other cannabinoid potency, and terpenoid potency;
158153 2. A statement indicating that the product has been tested for
159154 contaminants;
160155 3. One or more product warnings to be determined by the
161156 Department; and
162157 4. Any other information the Department deems necessary.
163158 SECTION 2. It being immediately necessary for the preservation
164159 of the public peace, health or safety, an emergency is hereby
160+declared to exist, by reason whereof this act shall take effect and
161+be in full force from and after its passage and approval.
165162
166-SENATE FLOOR VERSION - HB4288 SFLR Page 4
167-(Bold face denotes Committee Amendments) 1
163+ENGR. H. B. NO. 4288 Page 4 1
168164 2
169165 3
170166 4
171167 5
172168 6
173169 7
174170 8
175171 9
176172 10
177173 11
178174 12
179175 13
180176 14
181177 15
182178 16
183179 17
184180 18
185181 19
186182 20
187183 21
188184 22
189185 23
190186 24
191187
192-declared to exist, by r eason whereof this act shall take effect and
193-be in full force from and after its passage and approval.
194-COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES
195-April 11, 2022 - DO PASS AS AMENDED
188+Passed the House of Representatives the 23rd day of March, 2022.
189+
190+
191+
192+
193+ Presiding Officer of the House
194+ of Representatives
195+
196+
197+Passed the Senate the ___ day of __________, 2022.
198+
199+
200+
201+
202+ Presiding Officer of the Senate
203+
204+